Pharmaceuticals - Community Register


Community register of veterinary medicinal products


Product information

Invented name: Kexxtone   
Auth. number : EU/2/12/145
Active substance : Monensin sodium
ATC: Anatomical main group: QA - Alimentary tract and metabolism
Therapeutic subgroup: QA16 - Other alimentary tract and metabolism products
Pharmacological subgroup:
Chemical subgroup: QA16QA - Drugs for treatment of acetonemia
Chemical substance: QA16QA06 - Drugs for treatment of acetonemia
(See WHO ATCvet Index)
Indication: For the reduction in the incidence of ketosis in the peri-parturient dairy cow/heifer which is expected to develop ketosis
Marketing Authorisation Holder: Eli Lilly and Company Limited
Elanco Animal Health, Lilly House, Priestley Road, Basingstoke, Hampshire RG24 9NL, United Kingdom
EPAR and active package presentations

Package presentations

Information about presentations can be found in the website of the European Medicines Agency under the section "Product Information".
Likewise, presentations on which there has been a Commission decision are referred in the Summary of Product Characteristics (Annex I to the Commission Decision granting the marketing authorisation) which is available in the Community Register.

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
30/01/2013 Centralised - Authorisation EMEA/V/C/2235 (2013)529 of 28/01/2013
05/08/2013 Centralised - Variation (no change in Commission Decision) EMEA/V/C/2235/IB/2
28/05/2014 Centralised - Variation EMEA/V/C/2235/IG/437
Updated with Decision(2015)4103 of 10/06/2015
24/10/2014 Centralised - Variation EMEA/V/C/2235/IB/5
Updated with Decision(2015)4103 of 10/06/2015
12/06/2015 Centralised - Yearly update (2015)4103 of 10/06/2015